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ABSTRACT 
Fistula-in-ano is troublesome problem encountered in general practice. It consists of 1.6% of all surgical 
admissions and leads to physical, psychological and social problems. The management consists of multiple 
modalities with varied results. Present study evaluates medicated seton (Ksharsutra) as a minimal invasive 
modality of treatment. Methodology: The study was randomized control trial carried out at tertiary care 
hospital with an aim to assess the efficacy of Ksharsutra Vs fistulectomy. The subjects were clinically 
diagnosed and MRI confirmed cases of low fistula-in-ano. They were block randomized into two 
interventional groups. Study group were subjected to introduction of Ksharsutra under local anesthesia while 
control group under saddle block had a formal fistulectomy done. The outcome measures were wound 
healing time, hospital stay and recurrence. Results: A total of 63 patients were evaluated of which 33 were 
allocated to Ksharsutra group and 30 patients underwent fistulectomy. The male: female ratio was 8:1 and 
mean age of the patients was 38.4 years SD ± 11.03. Perianal sinus with or without pain and discharge was 
presenting complaints in all patients. 1/3rd patient gave history of past incision and drainage while 2/3rd 
patients had spontaneous rupture. Majority (76%) fistulae were intersphincteric and rest were 
transsphincteric. The mean healing duration was 5.5 weeks in fistulectomy and 6 weeks in Ksharsutra (p>0.1 
[NS]). Recurrence rate and incontinence rates were also significantly not different. Conclusion: The 
equivalence of results of Ksharsutra with traditional fistulectomy made it an alternative minimal invasive 
modality of treatment which can be offered on outpatient basis. 
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INTRODUCTION 
 Fistulae-in-ano forms a common treatable benign 
lesion of the rectum and anal canal. Most of the fistulae 
develop after rupture or inadequate drainage of pyogenic 
anorectal abscess which develop secondary to infection of 
the cryptic gland.1 The vast majority are contributed by 
acute infection whereas minority by chronic & low-grade 
infections pointing to varying etiologies. Patients below 
the age group of 40 years and non-diabetics appeared to 
have a higher risk for fistula formation resulting in loss of 
valuable productive man hours2. In India anal fistula 
constitutes 1.6% of all surgical admissions with chances of 
recurrence 0.7 to 26.5% & incidence of anal incontinence 5 
to 40%.3 
 Surgery for fistula-in-ano may account for 5% of 
the operative workload of a colorectal service4. The 
surgery itself thus constitutes only a small fraction of the 
work undertaken, but poorly performed surgery may 
result in considerable patient morbidity, including 
multiple re-operations and minor-to-major degrees of anal 
incontinence.  
 Setons have been used to manage fistula-in-ano 
for hundreds of years were commonly described only for 
the high or complex anal fistula in order to avoid faecal 
incontinence and recurrence5. The usage of this method 
was deemed cumbersome and too slow. 
 The aim of this study was to evaluate the role of 
Ayurvedic setons in treatment of low fistula-in-ano and 
compare it with established surgical treatment of 
fistulectomy. 
PATIENTS AND METHODS 
 The study was conducted at Department of 
Surgery in a Tertiary care Hospital after approval from 
hospital ethics committee. A sample of 63 patients with 
fistula-in-ano were enrolled in this hospital based 
randomized control trial. All patients presenting with 
fistula for more than 3 weeks, not responding in spite of 
adequate antibiotic therapy & local treatment, Internal 
opening clinically palpable and or visualized on 
proctoscopy and single or multiple external openings were 
included in the present study. All clinical and or 
histologically diagnosed cases of Crohn’s disease, 
Tuberculous fistula, immunocompromised patient and 
fistula with abscess were excluded. All patients were 
subjected to MRI scan of perineum region to know the type 
of fistula and edge biopsy of external opening were taken 
to rule out secondary fistula-in-ano. Using a predesigned 
proforma demographic factors like age, gender and causes 
of anal fistula which included previous abscess bursting, 
incision & drainage, recurrence after surgical procedure 
and clinical factors which included site of external opening, 
site of internal opening, number of openings, position of 
both openings, discharge from the opening, nature of 
discharge from both openings, recurrent fistulae, history of 
any previous anorectal surgery were studied. In view of 
operative procedure, patients were grouped under two 
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Categories, Fistulectomy and Medicated Seton 
(Ksharsutra) by block randomization of 10 by envelope 
method. Study group were subjected to introduction of 
Ksharsutra under local anesthesia while control group 
under saddle block had a formal fistulectomy done. The 
outcome measures were wound healing time and hospital 
stay calculated from day of procedure and recurrence of 
fistula and anal incontinence. 
RESULTS 
 A total of 67 subjects were enrolled in the present 
study of them 63 subjects fulfilled the inclusion criteria. 
The rest 4 cases were high anal fistulas & they were 
excluded from the study. 
 The mean age of the patient in the present study 
was 38.40 yrs SD ± 11.03.Out of 63 patients 56 (88.89%) 
were males & 7 (11.11%) were females suggesting age of 
occurrence of fistula in females was younger than males. 
All the patients presented with both pus discharge & pain. 
The mean duration of pus discharge was 12.62 months SD 
±10.05 & range of 1 – 48 months. A mean duration of pain 
was 13.16 months SD ± 9.72 & range of 1 – 39 months. Out 
of 63 patients, 22 patients (34.92%) underwent incision & 
drainage and 41 patients (65.08%) reported bursting of 
perianal abscess suggesting more patients develop fistula 
after spontaneous rupture of perianal abscess. Out of 63 
patients, 59 patients (93.65%) presented with single 
external opening, 3 patients (4.76%) with 2 external 
openings and only one patient (1.59%) with 3 external 
openings. Out of 68 external openings, 26 (38.24%) 
openings were found in 3 – 5 O’clock position followed by 
18 (28.57%) openings in 9 – 11 O’clock position followed 
by 14 (22.22%) openings in 6 – 8 O’clock position followed 
by 10 (15.87%) openings in 12 – 2 O’clock position 
suggesting majority of external opening was in posterior 
plane. Out of 63 internal openings majority of the internal 
openings 63.49% was situated in posterior midline and 
rest situated in anterior midline. On MRI scan, out of 67 
patients 51 (76.12%) were found to have Intersphincteric 
course, 12 (17.91%) patients were having 
Transsphincteric course and 4 (5.97%) patients were 
having Suprasphincteric course. 
 Out of 63 patients in the present study 31 patients 
(49.21%) underwent Fistulectomy & 32 patients (50.79%) 
underwent Medicated Seton (Ksharsutra) procedure. The 
basic demographic & clinical features of two groups when 
compared showed that they were similar suggesting 
adequate randomization of the two groups was 
statistically comparable on baseline characteristics. [Table 
1]  
Table 1: Showing comparison of Basic parameters of Fistulectomy & Medicated Seton (Ksharsutra) group 
 Fistulectomy Medicated Seton (Ksharsutra) p value 
Mean Age (years) 39.12 37.53 0.5310 
Gender 
Male 27 29 0.9645 
Female  4 3 
Pus Discharge Duration (months) 11.80 13.40 0.5318 
Pain Duration 11.58 14.69 0.2074 
MRI 
Type of Fistula 
Intersphincteric  26 26 0.7950 
Transphincteric 5 7 
 The mean healing duration in the present study 
was 40.98 days with SD ± 11.90 & range of 22 – 73 days. 
The result signifies equivalence between two modalities 
that is Fistulectomy & Medicated Seton (Ksharsutra) when 
healing was compared. Out of 31 patients of Fistulectomy 
in the present study 1 patient (3.23%) developed abscess 
which required I& D & none of the patient presented with 
recurrence & none of them presented with incontinence. 
Out of 32 patients of Medicated Seton (Ksharsutra) 2 
patients (6.25%) developed abscess which required 
Incision & drainage and 2 (6.25%) patients were 
presented with recurrence & none of them presented with 
incontinence. 
 Of all the histological findings of the 63 patients 
which was obtained from the tract or opening it was found 
to be chronic inflammation or dense mixed inflammation. 
 
DISCUSSION 
 Fistula-in-ano is a common perineal condition 
causing appreciable morbidity & inconvenience to patient. 
It is believed to originate from an infection of an anal 
gland. Majority of these fistulas are simple & low and 
identified by digital examination. They pose surgical 
challenge as surgical technique to perineum to damage 
anal sphincters leading to incontinence or incomplete 
removal leading to recurrence. Multiplicity of treatment 
modalities & lack of interest by a surgical faculty managing 
fistula leads to patients shifted from one clinic to another 
finally getting operated by an inexperienced surgeon or 
quack. The present study has aimed to assess the cause, 
presentation & management in Indian scenario. 
 A total of 67 patients were recruited in present 
study of them 4 excluded as they were suprasphincteric 
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fistula diagnosed by perineal MRI. The male female ratio 
was 8:1 with 38.4 years as the mean age of presentation. 
 All 63 patients presented with pain and perineal 
discharge. These findings were different from other 
published studies  
 Proper incision and drainage of the perineal 
abscess is associated with lesser incidence of fistula-in-
ano. These facts could be collaborated in the present study 
where 1/3rd of the patients give history of incision and 
drainage in the past, while spontaneous rupture of the 
abscess has led to increased occurrence of fistula-in-ano 
i.e., more than 2/3rd of the patients, emphasizing the need 
for incision and drainage of the perineal abscess to reduce 
the occurrence of fistula in future. These results are 
consistent with literature except Ahmed Uraiqat et al 
(2010)6 who has quoted a very high incidence of fistula 
development after incision and drainage. 
 Majority of 76% cases were belonging to 
intersphincteric group. This occurrence is distinctly higher 
than those quoted in literature ranging from 30 to 55%, 
the reason for which cannot be explained. The occurrence 
of suprasphincteric fistula quite matched with those 
reported in literature. 
 The optimal management of fistula is aimed at 
eradicating the fistula, preserving the anal sphincter, 
preventing the recurrence and allowing early return to 
normal activity. These were the real challenge in the 
present study. Hence patient once classified to be operable 
either in intersphincteric or transsphincteric group 
underwent either a Fistulectomy or Medicated Seton 
(Ksharsutra) therapy. The rationale for selecting 
Fistulectomy as one of the modes of management was due 
to very few studies done to evaluate the modalities. 
This modality of treatment has 2 advantages 
1. Most of the present series of fistula were low variety 
and the tract could be subjected to Histopathological 
examination after properly dissecting it out. 
2. Other advantage was finding associated tract while 
dissecting the main tract due to fibrous extensions. 
Table 2: Showing healing duration of Fistulotomy, Fistulectomy and Medicated Seton 
Study 
Fistulectomy 
(weeks) 
Fistulotomy 
(weeks) 
Medicated Seton 
(Ksharsutra) (weeks) 
Ahmad Uraiqat (2010)6 - 6 - 
K.S. HO. Et al (2001)7 - 4 8 
O. Kronborg (1985)8 5.51 6.28 - 
Present study 5.5 - 6 
 The results of Fistulectomy are quite consistent 
with series of Kronborg (1985)8 with healing duration of 
approximately 5 weeks. It is a fact that Fistulotomy is a 
more practised modality and Fistulectomy is avoided by 
most surgeons for the fear of dissection and more of 
perianal damage. But this procedure in the present study 
has given results similar to Fistulectomy with an added 
advantage of removal of diseased tract in toto. 
 Medicated Seton (Ksharsutra) has been used in 
Ayurveda since the time of Sushruta and being practised 
till today without any good clinical evidence. To make this 
ancient modality a more evidenced based treatment 
Ksharsutra was used and evaluated in the present study. 
The results of healing by Ksharsutra in the present study 
were quite consistent with very limited evidence in 
literature.6,7,8 
CONCLUSION 
 To summarise fistula-in-ano continues to remain 
challenging condition to manage despite surgical advances. 
The treatment objective remains the same, i.e., eradication 
of septic focus, alleviation of symptoms, effective fistula 
healing, prevention of recurrence, preservation of anal 
sphincter and rapid patient recovery. The present study 
was able to fulfil its aim to find out the etiological aspect as 
most of the fistulas were cryptoglandular in origin. The 
clinical manifestations were evaluated and were similar to 
those reported in literature. Perianal MRI was an 
important tool in classifying the fistula-in-ano and of great 
help in treatment planning. The role of conventional fistula 
surgery and ancient Ksharsutra were also evaluated and 
found to be promising. In this world of developing 
scientific advances, ancient modalities like Ksharsutra can 
be an important modality to be practised in surgical out-
patients. 
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Figure 1: Showing operative steps of Fistulectomy 
 
 
Figure 2: Showing operative steps of Medicated Seton (Ksharsutra) insertion 
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